HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

EN101

a 20-mer oligonucleotide that is chemically modified by the insertion of 2'-oxymethyl groups at the three terminal positions of the 3' end; selectively lowers AChE-R in blood and muscle yet leaves unaffected the synaptic variant AChE-S
Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hamra-Amitay, Yasmine: 2 articles (05/2006 - 04/2006)
2. Brenner, Talma: 2 articles (05/2006 - 04/2006)
3. Soreq, Hermona: 1 article (12/2012)
4. Sussman, Jon: 1 article (12/2012)
5. Apolski, Slobodan: 1 article (12/2012)
6. Wirguin, Yitzhak: 1 article (12/2012)
7. Argov, Zohar: 1 article (12/2012)
8. Milic-Rasic, Vedrana: 1 article (12/2012)
9. Wirguin, Itzhak: 1 article (05/2006)
10. Boneva, Neli: 1 article (05/2006)

Related Diseases

1. Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
2. Myasthenia Gravis
3. Inflammation
4. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

Related Drugs and Biologics

1. Messenger RNA (mRNA)